Prise en charge de la maladie du greffon contre l’hôte chronique : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)-Reference-Cited by-同舟云学术

Prise en charge de la maladie du greffon contre l’hôte chronique : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Published:2017-12 Issue:12 Volume:104 Page:S145-S168
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Magro Leonardo,Forcade Edouard,Giraud Christine,Granata Angela,Parquet Nathalie,Rohrlich Pierre-Simon,Terriou Louis,Yakoub-Agha Ibrahim,Beguin Yves

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference23 articles.

1. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report;Filipovich;Biol Blood Marrow Transplant,2005

2. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD;Couriel;Blood,2006

3. How we treat chronic graft-versus-host disease;Flowers;Blood,2015

4. Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease;Koreth;Blood,2016

5. Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD;Magro;Bone Marrow Transplant,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy;Bone Marrow Transplantation;2023-03-27

2. Infectious risks in patients treated with extracorporeal photopheresis for graft‐versus‐host disease: A retrospective cohort study;Journal of Clinical Apheresis;2021-12-30

3. Prise en charge de la GVH digestive aiguë : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2021-12

4. Complications stomatologiques dans le contexte de l’allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2020-12